Alvotech (ALVO) Stock Price, Quote, News & History

PRO

Why Is It Moving?™:Alvotech shares are trading higher after the company announced FDA approval...

Key Statistics

Open

$5.14

Volume / Avg.

258.62K / 1.09M

Day Range

$5.13 - $5.24

52 Wk Range

2.94 - 8.74

Market Cap

$1.76B

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

4.47%

Days to Cover

Recent Alvotech SA News

LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday

U.S. stocks mixed as Nasdaq rises; LuxExperience jumps 13.5% on strong sales, while Einride, Forgent, Cipher and others post gains.

Avi Kapoor

Rapport Therapeutics To Rally Around 76%? Here Are 10 Top Analyst Forecasts For Wednesday

Analysts raised targets for RAPP, ALLR, UNP and ALVO; cut targets for NU, CLLS and JBHT, with several rating upgrades and downgrades.

Avi Kapoor

This Union Pacific Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Analysts upgraded Similarweb, Rocket Pharmaceuticals, Radiant Logistics and Ulta Beauty; Paychex rose to Peer Perform, with targets raised.

Avi Kapoor

Crude Oil Down 3%; XPeng Shares Fall After Q2 Results

US stocks traded mixed with the Dow Jones index gaining over 150 points. Consumer staples shares jumped while information technology stocks fell. XPeng Inc shares fell 7% due to wider than expected loss and lower revenue outlook.

Avi Kapoor

Napco Security Technologies Posts Upbeat Q4 Results, Joins Alvotech, Rum Group And Other Big Stocks Moving Higher On Monday

The text discusses recent gains in the stock market, particularly for companies like Napco Security Technologies and SuperX AI Technology. US stocks were mixed, with the Dow Jones index gaining 150 points. Napco Security Technologies rose after better-than-expected results. Other big gainers include SuperX AI, Evolution Metals, and Cleveland-Cliffs.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-198.70M

Investing Cash Flow (TTM)

-146.18M

Financing Cash Flow (TTM)

335.93M

Free Cash Flow (TTM)

-333.82M

Capital Expenditure (TTM)

-135.12M

Net Change in Cash (TTM)

-8.95M

Analyst Trends and Forecast

Aug

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$3.14B

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

3.09

PB Ratio (TTM)

Earnings Yield % (TTM)

-12.07%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

20.70

Price / EBITDA (TTM)

10.03

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.54

Company Debt

Total Debt

$1.31B

LT Debt

$1.26B

LT Debt Issuance (TTM)

$239.69M

LT Debt Repayment (TTM)

-$49.47M

Total Cash

$142.75M

Debt to Equity

Issuance of Debt (TTM)

$190.22M

Repayment of Debt (TTM)

-$49.47M

Key Statistics

Open

$5.14

Volume / Avg.

258.62K / 1.09M

Day Range

$5.13 - $5.24

52 Wk Range

2.94 - 8.74

Market Cap

$1.76B

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

4.47%

Days to Cover

About Alvotech

Sector

Health Care

Industry

Biotechnology

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

How do I buy Alvotech (ALVO) stock?

You can purchase shares of Alvotech (NASDAQ:ALVO) through any online brokerage.

View our list of the best stock brokerages

Who are Alvotech (ALVO) competitors?

Other companies in Alvotech’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).

What is the forecast, or price target, for Alvotech (ALVO) stock?

Alvotech has a consensus price target of $10.71.

What is the current price for Alvotech (ALVO)?

The stock price for Alvotech (NASDAQ: ALVO) is $5.19 last updated October 21, 2026 at 9:22 AM EDT.

Does Alvotech (ALVO) pay a dividend?

There are no upcoming dividends for Alvotech.

When is Alvotech (NASDAQ:ALVO) reporting earnings?

Alvotech does not have any upcoming earnings scheduled.

Is Alvotech (ALVO) going to split?

There is no upcoming split for Alvotech.

What sector and industry does Alvotech (ALVO) operate in?

Alvotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Key Statistics

Open

$5.14

Volume / Avg.

258.62K / 1.09M

Day Range

$5.13 - $5.24

52 Wk Range

2.94 - 8.74

Market Cap

$1.76B

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

4.47%

Days to Cover

Recent Alvotech SA News

LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday

U.S. stocks mixed as Nasdaq rises; LuxExperience jumps 13.5% on strong sales, while Einride, Forgent, Cipher and others post gains.

Avi Kapoor

Rapport Therapeutics To Rally Around 76%? Here Are 10 Top Analyst Forecasts For Wednesday

Analysts raised targets for RAPP, ALLR, UNP and ALVO; cut targets for NU, CLLS and JBHT, with several rating upgrades and downgrades.

Avi Kapoor

This Union Pacific Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Analysts upgraded Similarweb, Rocket Pharmaceuticals, Radiant Logistics and Ulta Beauty; Paychex rose to Peer Perform, with targets raised.

Avi Kapoor

Crude Oil Down 3%; XPeng Shares Fall After Q2 Results

Avi Kapoor

Napco Security Technologies Posts Upbeat Q4 Results, Joins Alvotech, Rum Group And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-198.70M

Investing Cash Flow (TTM)

-146.18M

Financing Cash Flow (TTM)

335.93M

Free Cash Flow (TTM)

-333.82M

Capital Expenditure (TTM)

-135.12M

Net Change in Cash (TTM)

-8.95M

Analyst Trends and Forecast

Aug

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$3.14B

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

3.09

PB Ratio (TTM)

Earnings Yield % (TTM)

-12.07%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

20.70

Price / EBITDA (TTM)

10.03

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.54

Company Debt

Total Debt

$1.31B

LT Debt

$1.26B

LT Debt Issuance (TTM)

$239.69M

LT Debt Repayment (TTM)

-$49.47M

Total Cash

$142.75M

Debt to Equity

Issuance of Debt (TTM)

$190.22M

Repayment of Debt (TTM)

-$49.47M

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

How do I buy Alvotech (ALVO) stock?

You can purchase shares of Alvotech (NASDAQ:ALVO) through any online brokerage.

View our list of the best stock brokerages

Who are Alvotech (ALVO) competitors?

What is the forecast, or price target, for Alvotech (ALVO) stock?

Alvotech has a consensus price target of $10.71.

What is the current price for Alvotech (ALVO)?

The stock price for Alvotech (NASDAQ: ALVO) is $5.19 last updated October 21, 2026 at 9:22 AM EDT.

Does Alvotech (ALVO) pay a dividend?

There are no upcoming dividends for Alvotech.

When is Alvotech (NASDAQ:ALVO) reporting earnings?

Alvotech does not have any upcoming earnings scheduled.

Is Alvotech (ALVO) going to split?

There is no upcoming split for Alvotech.

What sector and industry does Alvotech (ALVO) operate in?

Alvotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Key Statistics

Open

$5.14

Volume / Avg.

258.62K / 1.09M

Day Range

$5.13 - $5.24

52 Wk Range

2.94 - 8.74

Market Cap

$1.76B

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

4.47%

Days to Cover

About Alvotech

Sector

Health Care

Industry

Biotechnology